Skip to main content
. Author manuscript; available in PMC: 2014 Dec 5.
Published in final edited form as: Eur J Pharmacol. 2013 Sep 25;721(0):10.1016/j.ejphar.2013.09.035. doi: 10.1016/j.ejphar.2013.09.035

Figure 1.

Figure 1

The compound structures of the neurotensin NTS1 receptor agonist PD149163 (left), atypical antipsychotic drug clozapine (center), and dopamine D2/3 antagonist and typical antipsychotic drug raclopride (right).